Novo Nordisk: Doing Nicely

While American drug companies Merck (MRK) and Pfizer (PFE) aren't doing well (or at least Merck has bounced off its deep lows rather nicely), check out the performance of Denmark's Novo Nordisk A/S (NVO):

Click to Enlarge

The stock is up about $5 a share today to $106. I had to cut off the top part of the chart because it's a logarithmic scale, but you get the idea.